Far West Podiatry Podiatrist - Foot Surgery Medicare: Medicare Enrolled Practice Location: 13624 Hawthorne Blvd Ste 206, Hawthorne, CA 90250 Phone: 310-675-0900 Fax: 310-675-0904 |
Dr. Derick Alan Ball, DPM Podiatrist - Foot Surgery Medicare: Accepting Medicare Assignments Practice Location: 13624 Hawthorne Blvd, Suite 206, Hawthorne, CA 90250 Phone: 310-675-0900 Fax: 310-675-0904 |
Dr. Eugene Marvin Krank Jr., D.P.M. Podiatrist - Foot Surgery Medicare: Not Enrolled in Medicare Practice Location: 4358 W 136th St, #d, Hawthorne, CA 90250 Phone: 310-219-3339 |
Dr. Robert Paoletti, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 4477 W. 118th St., Ste 105, Hawthorne, CA 90250 Phone: 310-679-2251 Fax: 310-679-9387 |
Dr. Karen Lynn Wrubel, DPM Podiatrist - Foot Surgery Medicare: Accepting Medicare Assignments Practice Location: 13624 Hawthorne Blvd, Suite 206, Hawthorne, CA 90250 Phone: 310-675-0900 Fax: 310-675-0904 |
News Archive
Patricia Dickson, MD, and Jennifer Yee, MD, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) researchers, will be honored on Thursday as recipients of the first UCLA Clinical and Translational Science Institute's (CTSI) Award for Translational Research in Maternal, Child, and Adolescent Health.
Amgen announced today that results from a Phase 2 trial evaluating the safety and efficacy of brodalumab in 198 patients with moderate to severe plaque psoriasis were published in the New England Journal of Medicine.
How can the United States foster long-term economic growth? A new report suggests that one of the best ways is through investment in the basic research that leads to innovation and job creation. "Sparking Economic Growth: How federally funded university research creates innovation, new companies and jobs" released today by The Science Coalition identifies 100 "success stories" - examples of companies that are the result of federal investments in basic research.
Calypso Medical Technologies, Inc., a developer of targeting technology used for accurate, precise real-time tracking of tumor targets, today announced the online publication of a clinical study in Urology (The GOLD JOURNAL). The prospective, multi-site study, entitled, "Assessing the Impact of Margin Reduction (AIM)," is the first outcomes-based study to evaluate the quality of life of high-dose intensity-modulated radiotherapy (IMRT) to the prostate with tightly contoured treatment technically described as "reduced treatment margins."
This weekend, hundreds of home care and hospice providers arrive in Washington, DC, for the National Association for Home Care & Hospice March on Washington taking place March 22-25, 2015. NAHC's conference will raise awareness of key policy issues impacting providers and their ability to care for the growing number of Americans who rely on home health.
› Verified 3 days ago